title: Intracolonic bioavailability of human calcitonin in man.
abstract: Human calcitonin (hCT) injected into the lumen of the descending colon of normal human subjects was absorbed within minutes and could be recognized intact in plasma as shown by RIA in combination with reverse-phase HPLC. The absorption was low and variable, with bioavailabilities ranging from 0.01% to 2.7% relative to intravenously administered hCT (area under the concentration-time curve). With intravenous hCT serum calcium was lowered and the fractional urinary excretion of calcium, phosphorus, sodium and chloride was significantly stimulated. With the intracolonic hCT, the fractional urinary excretions of calcium, sodium and chloride were also marginally stimulated relative to intracolonic vehicle (placebo). In conclusion, hCT is absorbed intact from the colon, but the bioavailability is low and highly variable.
authors: Department of Research, University Hospital, Basel, Switzerland.
authors: C
authors: C
authors: Beglinger
authors: W
authors: W
authors: Born
authors: R
authors: R
authors: Muff
authors: J
authors: J
authors: Drewe
authors: J L
authors: JL
authors: Dreyfuss
authors: A
authors: A
authors: Bock
authors: M
authors: M
authors: Mackay
authors: J A
authors: JA
authors: Fischer
mesh_terms: D000328:Adult; D001682:Biological Availability; D002116:Calcitonin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D003106:Colon / Q000378:metabolism*; D006801:Humans; D007262:Infusions, Intravenous; D007267:Injections; D007408:Intestinal Absorption; D008297:Male; D012016:Reference Values
chemical_list: D002116:Calcitonin